Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-β levels in a mouse model of alzheimer's disease

Biochemistry, Genetics and Molecular Biology

• Mammalian Target of Rapamycin 100%
• Mouse Model 25%
• Mouse 25%
• Lifespan 18%
• Transgenic Mouse 12%
• Autophagy 12%
• Transgenics 12%
• Organisms 6%
• Amyloid 6%
• Aging 6%
• Cognition 6%
• Age 6%
• Reduction (Chemistry) 6%
• Species 6%

Medicine and Dentistry

• Rapamycin 43%
• Lifespan 18%
• Diseases 12%
• Cognitive Defect 12%
• Transgenic Mouse 12%
• Autophagy 12%
• Therapeutic Procedure 12%
• Aging 6%
• Amyloid 6%
• Alzheimer's Disease 6%
• Cognition 6%
• Therapeutic Agent 6%
• Age 6%
• Species 6%
• Organism 6%
• Brain Tissue 6%

Neuroscience

• Autophagy 12%
• Cognitive Disorders 12%
• Neuron 12%
• In Vivo 6%
• Amyloid 6%
• Brain 6%